Samarpita Mohanty

140 posts

Samarpita Mohanty banner
Samarpita Mohanty

Samarpita Mohanty

@Samarpitaa_

Radiation Oncologist | Head and Neck Cancer ☢️ @RadOncTMC

Mumbai, India Katılım Nisan 2010
577 Takip Edilen338 Takipçiler
Samarpita Mohanty retweetledi
Manas Muduli
Manas Muduli@manas_muduli·
A new star rises in Indian para archery!! Odisha’s Payal Nag defeats reigning world champion Sheetal Devi to win GOLD at the World Archery Para Series 2026 in Bankok. Payal is the world’s first archer to compete without any limbs. She lost all four limbs in an electrocution accident during childhood. India is proud. Odisha is proud. 🙏🔥 🎥 World Archery
English
61
869
3.4K
57.7K
Samarpita Mohanty retweetledi
TMC Radiation Oncology
TMC Radiation Oncology@RadOncTMC·
Radiotherapy for Sino-nasal Tumors Pre-Conference Workshop | EBM 2026 @TataMemorial A focused, case-based academic update on one of the most challenging sites in head and neck oncology. 26 Feb 26 @TataMemorial, Mumbai 🔗 tinyurl.com/7jehde9p Don't miss the opportunity!
TMC Radiation Oncology tweet mediaTMC Radiation Oncology tweet media
English
0
4
8
639
Samarpita Mohanty retweetledi
TMC Radiation Oncology
TMC Radiation Oncology@RadOncTMC·
From cobalt in 1959 to proton therapy in 2023, our journey @RadOncTMC has been one of service, training, & innovation. Proud to stand strong this @WorldRTDay, shaping cancer care across India & beyond as we advocate for timely, equitable access to RT #OneVoiceForRadiotherapy
TMC Radiation Oncology tweet mediaTMC Radiation Oncology tweet mediaTMC Radiation Oncology tweet mediaTMC Radiation Oncology tweet media
English
3
35
108
7.9K
Samarpita Mohanty retweetledi
Gustavo
Gustavo@gusviani·
🚨 New Evidence in High-Risk Thyroid Cancer: Can Radiotherapy Make the Difference? 🎯 Objective Evaluate outcomes & toxicity of adjuvant IMRT in high-risk differentiated thyroid cancer (DTC) 🏥 Methods •Retrospective, single-center (2011–2024) •59 high-risk DTC pts (gross ETE, +margins, aggressive histology) •IMRT + IGRT, 60–64 Gy to high-risk, 54 Gy to low-risk volumes •Median follow-up: 53 mo 📊 Key Results •5-yr locoregional control: 89.3% •5-yr OS: 84.6% •Acceptable toxicity (Grade ≥3 dermatitis 12%, dysphagia 10%) 💡 Take-home: Targeted adjuvant IMRT can achieve excellent control in selected high-risk DTC pts
Gustavo tweet mediaGustavo tweet mediaGustavo tweet media
English
2
14
39
2.5K
Samarpita Mohanty retweetledi
TMC Radiation Oncology
TMC Radiation Oncology@RadOncTMC·
Honored to share highlights of @ReenaEngineer’s presentation of POLCAGB phase III trial at #ASCO2025, a game changer for locally advanced gallbladder cancer Neoadj CRT vs CT alone: 🌟 Nearly doubled mOS (21.8 vs 10.1 months) 🌟 Significantly improved R0 resection (51.6% vs 29.7%)
TMC Radiation Oncology tweet mediaTMC Radiation Oncology tweet mediaTMC Radiation Oncology tweet mediaTMC Radiation Oncology tweet media
English
4
56
151
11.3K
Samarpita Mohanty retweetledi
TMC Radiation Oncology
TMC Radiation Oncology@RadOncTMC·
📢 New publication alert from Head & Neck team @RadOncTMC! Unique data on 83 second primary malignancies (SPMs) from a 900-patient RCT in HNSCC shows encouraging survival with aggressive multimodality salvage, including surgery. doi.org/10.1016/j.rado…
TMC Radiation Oncology tweet media
English
0
8
24
1.5K
Samarpita Mohanty retweetledi
Jeff Ryckman
Jeff Ryckman@jryckman3·
A fantastic prospective report on H&N #reirradiation from the Tata Memorial group, one of the largest prospective H&N ReRT reports published. 📌 Patient selection = Crucial. Looking forward to detailed reporting of cumulative RT1 and RT2 dosimetry! sciencedirect.com/science/articl…
Jeff Ryckman tweet mediaJeff Ryckman tweet mediaJeff Ryckman tweet mediaJeff Ryckman tweet media
English
0
32
68
4.7K
Samarpita Mohanty retweetledi
Tata Memorial Hospital
Tata Memorial Hospital@TataMemorial·
Witness the extraordinary resolve of Dr. Vanita Noronha as she transforms her breast cancer experience into a story of hope and resilience. Watch the video now. 🔗 youtu.be/fNJg8fSrvmo?fe…
YouTube video
YouTube
English
14
67
171
20.5K
Samarpita Mohanty retweetledi
Pramesh CS
Pramesh CS@cspramesh·
Issued in public interest
Pramesh CS tweet media
English
258
2.8K
8.1K
912.9K
Odisha Eco Retreats
Odisha Eco Retreats@ecoretreat_ot·
Eco Retreat Konark is Back! Experience the ultimate luxury amidst nature with premium tents, exquisite cuisine, thrilling water sports, and unforgettable moments.
Odisha Eco Retreats tweet media
English
2
0
4
193
Samarpita Mohanty retweetledi
TMC Radiation Oncology
TMC Radiation Oncology@RadOncTMC·
Also happening now!! 'Chemo-Radiation Related Dysphagia Intervention: Pre-habilitation to Rehabilitation in Head and Neck Cancer' workshop @ACTREC_TMC
TMC Radiation Oncology tweet mediaTMC Radiation Oncology tweet media
English
1
4
10
820
Samarpita Mohanty retweetledi
TMC Radiation Oncology
TMC Radiation Oncology@RadOncTMC·
Happening now!! 'Brachytherapy for Oral Cavity Cancers: The Science and Art' workshop @TataMemorial
TMC Radiation Oncology tweet mediaTMC Radiation Oncology tweet mediaTMC Radiation Oncology tweet mediaTMC Radiation Oncology tweet media
English
1
3
11
463
Samarpita Mohanty retweetledi
TMC Radiation Oncology
TMC Radiation Oncology@RadOncTMC·
@sarbani30 presenting results of 'Feeding Tube Strategy during Radical Radiotherapy in Head & Neck Cancer: Phase III Randomised Trial'
TMC Radiation Oncology tweet mediaTMC Radiation Oncology tweet media
English
2
4
21
767